Authors:
Sasaki, S
Kanda, T
Ishibashi, N
Yamamoto, F
Haradahira, T
Okauchi, T
Meda, J
Suzuki, K
Maeda, M
Citation: S. Sasaki et al., 4,5,9,10-Tetrahydro-1,4-ethanobenz[b]quinolizine as a prodrug for its quinolizinium cation as a ligand to the open state of the TCP-binding site of NMDA receptors, BIOORG MED, 11(4), 2001, pp. 519-521
Authors:
Haradahira, T
Zhang, MR
Maeda, J
Okauchi, T
Kida, T
Kawabe, K
Sasaki, S
Suhara, T
Suzuki, K
Citation: T. Haradahira et al., A prodrug of NMDA/glycine site antagonist, L-703,717, with improved BBB permeability: 4-acetoxy derivative and its positron-emitter labeled analog, CHEM PHARM, 49(2), 2001, pp. 147-150
Authors:
Haradahira, T
Zhang, MR
Maeda, J
Okauchi, T
Kawabe, K
Kida, T
Suzuki, K
Suhara, T
Citation: T. Haradahira et al., A strategy for increasing the brain uptake of a radioligand in animals: Use of a drug that inhibits plasma protein binding, NUCL MED BI, 27(4), 2000, pp. 357-360
Authors:
Ishibashi, N
Kuwamura, T
Sano, H
Yamamoto, F
Haradahira, T
Suzuki, K
Suhara, T
Sasaki, S
Maeda, M
Citation: N. Ishibashi et al., Synthesis and evaluation of F-18- and C-11-labelled 9,10-ethanobenzo[b]quinolizinium derivatives for imaging of the NMDA receptor at the TCP-binding site, J LABEL C R, 43(4), 2000, pp. 375-383
Citation: M. Sasaki et al., Effect of dissolved gas on the specific activity of N-13 labeled ions generated in water by the O-16(p,alpha)N-13 reaction, RADIOCH ACT, 88(3-4), 2000, pp. 217-220
Citation: T. Haradahira et K. Suzuki, An improved synthesis of [C-11]L-703,717 as a radioligand for the glycine site of the NMDA receptor, NUCL MED BI, 26(2), 1999, pp. 245-247